Literature DB >> 3687580

Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonists.

W S Marshall1, C A Whitesitt, T Goodson, C Roman, L Rinkema, J H Fleisch.   

Abstract

LY171883 is an orally active antagonist of leukotriene (LT) D4 and LTE4. A series of related compounds varying the position and nature of the alkyl side chain were synthesized and evaluated for their ability to block LTD4-induced contraction of guinea pig ileum. Maximal activity was obtained with n-propyl, n-butyl, and n-pentyl substituents with slightly reduced activity for longer side chains. Polar groups on the side chain substantially reduced activity. Thus, it appears that the leukotriene receptor site requires a nonpolar alkyl group of moderate size at the 3-position on this type of receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3687580     DOI: 10.1007/bf01966489

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  2 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; D Swanson-Bean; T Goodson; P P Ho; W S Marshall
Journal:  J Pharmacol Exp Ther       Date:  1985-04       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.